Advertisement

Ads Placeholder
Loading...

CG Oncology, Inc. Common stock

CGON•NASDAQ
Healthcare
Biotechnology
$67.48
$0.69(1.03%)
U.S. Market opens in 25h 24m

CG Oncology, Inc. Common stock (CGON) Stock Overview

Explore CG Oncology, Inc. Common stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.7B
P/E Ratio-32.40
EPS (TTM)$-2.08
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$52.70
3 Months$59.15
1 Year Target$64.46

CGON Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CG Oncology, Inc. Common stock (CGON) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $64.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -32.40 and a market capitalization of 5.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.03%
5-Day Change
0.52%
1-Month Change
11.45%
3-Month Change
61.47%
6-Month Change
69.46%
Year-to-Date (YTD) Change
61.47%
1-Year Change
260.09%
3-Year Change
81.54%
5-Year Change
81.54%
All-Time (Max) Change
81.54%

Contact Information

https://cgoncology.com
NaN
400 Spectrum Center Drive, Irvine, DE, NaN

Company Facts

1,130 Employees
IPO DateJan 25, 2024
CountryUS
Actively Trading

Frequently Asked Questions